Dongkook Pharmaceutical Co Ltd banner
D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 18 100 KRW -0.28% Market Closed
Market Cap: ₩818.7B

Wall Street
Price Targets

Price Targets Summary
Dongkook Pharmaceutical Co Ltd

Wall Street analysts forecast Dongkook Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 25 500 KRW with a low forecast of 25 250 KRW and a high forecast of 26 250 KRW.

Lowest
Price Target
25 250 KRW
40% Upside
Average
Price Target
25 500 KRW
41% Upside
Highest
Price Target
26 250 KRW
45% Upside
Dongkook Pharmaceutical Co Ltd Competitors:
Price Targets
FCNCA
First Citizens BancShares Inc (Delaware)
17% Upside
THRY
Thryv Holdings Inc
261% Upside

Revenue
Forecast

13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 13%. The projected CAGR for the next 4 years is 12%.

Operating Income
Forecast

11% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 4 years is 16%.

Net Income
Forecast

12% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
12% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 12%. The projected CAGR for the next 3 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Dongkook Pharmaceutical Co Ltd's stock price target?
Price Target
25 500 KRW

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 25 500 KRW with a low forecast of 25 250 KRW and a high forecast of 26 250 KRW.

What is Dongkook Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 13%. The projected CAGR for the next 4 years is 12%.

What is Dongkook Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
16%

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 4 years is 16%.

What is Dongkook Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
16%

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 12%. The projected CAGR for the next 3 years is 16%.

Back to Top